Skip to main content

and
  1. No Access

    Article

    Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinoma

    Rapid development of drug resistance after chemotherapy is a major cause of treatment failure in individuals with pancreatic ductal adenocarcinoma (PDAC). In this study, we illustrate that tumor-derived interl...

    Huizhi Sun, Yi Ge, **g Liu, Zengxun Li, Hui Li, Tiansuo Zhao, **uchao Wang in Oncogene (2024)

  2. Article

    Open Access

    Correction: BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

    Chongbiao Huang, Hui Li, Yang Xu, Chao Xu in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

    VEGF inhibitors are one of the most successful antiangiogenic drugs in the treatment of many solid tumors. Nevertheless, pancreatic adenocarcinoma (PAAD) cells can reinstate tumor angiogenesis via activation o...

    Chongbiao Huang, Hui Li, Yang Xu, Chao Xu in Signal Transduction and Targeted Therapy (2023)

  4. Article

    Open Access

    Zeb1-induced metabolic reprogramming of glycolysis is essential for macrophage polarization in breast cancer

    Aerobic glycolysis (the Warburg effect) has been demonstrated to facilitate tumor progression by producing lactate, which has important roles as a proinflammatory and immunosuppressive mediator. However, how a...

    Huimin Jiang, Huimin Wei, Hang Wang, Zhaoyang Wang, Jianjun Li in Cell Death & Disease (2022)

  5. Article

    Correction to: Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2

    A Correction to this paper has been published: https://doi.org/10.1038/s41388-021-01652-5

    Guanwen Wang, Juan Wang, Antao Chang, Dongmei Cheng, Shan Huang, Dan Wu in Oncogene (2021)

  6. No Access

    Article

    Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2

    While mechanisms for metastasis were extensively studied in cancer cells from patients with detectable tumors, pathways underlying metastatic dissemination from early lesions before primary tumors appear are p...

    Guanwen Wang, Juan Wang, Antao Chang, Dongmei Cheng, Shan Huang, Dan Wu in Oncogene (2020)

  7. No Access

    Article

    Her2 promotes early dissemination of breast cancer by suppressing the p38-MK2-Hsp27 pathway that is targetable by Wip1 inhibition

    Cancer can metastasize from early lesions without detectable tumors. Despite extensive studies on metastasis in cancer cells from patients with detectable primary tumors, mechanisms for early metastatic dissem...

    Juan Wang, Guanwen Wang, Dongmei Cheng, Shan Huang, Antao Chang, **aoming Tan in Oncogene (2020)

  8. Article

    Open Access

    TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways

    TIFA, also called T2BP, was first identified using yeast two-hybrid screening. Our previous work showed that TIFA suppresses hepatocellular carcinoma (HCC) progression via apoptosis and cell cycle arrest. Howe...

    Wenzhi Shen, Renle Du, Jun Li, in Signal Transduction and Targeted Therapy (2016)